taysha gene therapies

Here Are the Winners of The Innovation Awards 2023

by | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District. Here's a full list of winners and finalists.
MORE
Taysha Gene Therapies Replaces CEO, Appoints R&D Chief
by | Dec 19, 2022

Dallas-based Taysha Gene Therapies is starting a new chapter in its fight to tackle devastating neurological conditions with changes in its top executive leadership.

Late Friday, the publicly traded biotech announced that Sean P....

MORE
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE
funding acquired
Follow the Money: ParkHub Acquires Parking Software Startup, UpSmith Raises $3.3M, Maverick Bancshares Seeks $17M for new Fort Worth Bank, and More
by | Oct 28, 2022
In this week’s North Texas deal flow, you’ll also find news about Taysha Gene Therapies landing a $50M investment; music tech startup MAX’s Series B raise; Dallas Venture Capital’s latest investment; Tyler Technologies’ $68M acquisition of Rapid Financial Solutions; NaturalShrimp hitting the Nasdaq Capital Market; and more.
MORE

Center of Gravity: Capital Factory Kicks Off New Dallas Digs With Startup Crawl and Health Supernova Event

by | May 6, 2022
Earlier this week, the Austin-based accelerator and investor announced its plans to launch a Center for Health Innovation at Pegasus Park in Dallas.
MORE
Follow the Money: D.R. Horton Acquires Public Water Resources Firm, Critical Start Raises $215M, Fort Worth Biotech VC Raises New Funds, and More
by | Apr 15, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE
Seed Accelerator Health Wildcatters Is Moving to Dallas’ Pegasus Park
by | Jan 25, 2022
The accelerator will move this summer from its downtown Dallas location to 6,000 square feet of collaborative and flexible office space in Pegasus Park's 18-story tower. Just weeks ago, Pegasus Park landed one of its biggest tenants to date: UT Southwestern‘s Office for Technology Development and other UTSW entities will be leasing six floors in the tower. 
MORE
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE

Success in the Genes: Launching in a Pandemic Didn’t Hurt This Fast-Growth Dallas Biotech Company

by | Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE
Through Roles at UTSW and Pegasus Park, Claire Aldridge Leads Efforts to Make DFW a Key Center for Healthcare Innovation
With an entrepreneurial mindset, Aldridge turns scientific discoveries into real-world solutions. Here's how Aldridge is playing a large role in making Dallas a destination for biotech and life sciences.
MORE
Taysha and UTSW Launch Innovation Fund to Advance the Development of New Gene Therapies
by | Jan 13, 2021
The expanded alliance between Taysha and UTSW, which dates back to when Taysha emerged from stealth in April 2020, will support the discovery of novel gene therapy candidates and technologies in new disease areas.
MORE
R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Dallas Gene Therapy Startup Closes $95M Series B to Bolster its Initial Clinical Studies
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE